Prior to joining AMRI in 2016, Dawn Von Rohr served as vice president and general manager of global APIs for Mallinckrodt Pharmaceuticals and was on the executive leadership team that led the successful spin-off of Mallinckrodt from Covidien. After joining Mallinckrodt in 1994, she held positions with increasing responsibility in research and development and sales and marketing. Prior to Mallinckrodt, Ms. Von Rohr was in the quality department at Schering Plough. She served as an extended board member of the Drug, Chemical & Associated Technologies Association (DCAT) from 2013 to 2015. She holds a bachelor’s in chemistry from Vanderbilt University and an MBA from Washington University in St. Louis.